©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454
Figure 8 SLC39A14 in cell proliferation.
A: Cell counting kit-8 (CCK-8) assay in Huh7 cells after SLC39A14 overexpression; B: CCK-8 assay in Huh7 cells after SLC39A14 knockdown; C: Colony formation experiment in Huh7 cells after SLC39A14 overexpression; D: Colony formation experiment in Huh7 cells after SLC39A14 knockdown. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Guo W, Wang MX, Mu T, Xu K, Jiang ZD, Wan XH, Li JW, Yi YX. Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 111454
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/111454.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.111454